Viewing Study NCT04980495


Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2025-12-26 @ 12:23 AM
Study NCT ID: NCT04980495
Status: COMPLETED
Last Update Posted: 2025-11-05
First Post: 2021-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis
Sponsor: argenx
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module